Pharma Communication and Education for Stakeholders (Personalized Medicine: What Pharma Should Do to Get Ready)

In Part 5 of the series, ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses how pharmaceutical companies should communicate with and educate stakeholders to ensure test adoption.|In Part 5 of the series, ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses how pharmaceutical companies should communicate with and educate stakeholders to ensure test adoption.|In Part 5 of the series, ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses how pharmaceutical companies should communicate with and educate stakeholders to ensure test adoption.|In Part 5 of the series, ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses how pharmaceutical companies should communicate with and educate stakeholders to ensure test adoption.